Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Wilson

Showing results (131-140 of 164) with videos related to

Pageof 17
Sort By:
The Lancet. Oncology|October 3, 2024
Development of a conceptual framework for an electronic patient-reported outcome (ePRO) system measuring symptoms and impacts of CAR T-cell therapies in patients with haematological malignanciesForam Khatsuria, Christel McMullan, Olalekan Lee Aiyegbusi, et al.
Translational Oncology|January 1, 2018
Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case-Control Study of Patients with Head and Neck Squamous Cell CarcinomaTrisha Wise-Draper, Arun Sendilnathan, Sarah Palackdharry, et al.
Cancer Research|April 3, 2003
PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancerElaine B Brunschwig, Keith Wilson, David Mack, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2004
15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancersMin Yan, Ronald M Rerko, Petra Platzer, et al.
Journal of Wound Care|March 20, 2025
Remote digital surgical wound monitoring and surveillance using smartphonesMelissa Rochon, Kylie Sandy-Hodgetts, Ria Betteridge, et al.
Oncotarget|April 19, 2017
Targeting CD157 in AML using a novel, Fc-engineered antibody constructChristina Krupka, Felix S Lichtenegger, Thomas Köhnke, et al.
Cardio-Oncology (London, England)|May 20, 2026
Cardio-oncology research prioritisation in the United Kingdom: national surveys of health care professionals, patients and carersGerard M Walls, Allyson Arnold, David Austin, et al.
Blood Advances|April 14, 2023
Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDSJustin Loke, Nicholas McCarthy, Aimee Jackson, et al.
The Journal of Infectious Diseases|March 18, 2021
A Human Dectin-2 Deficiency Associated With Invasive AspergillosisJames S Griffiths, P Lewis White, Magdalena A Czubala, et al.
Blood|October 5, 2017
Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2Hasan Hashem, Ashish R Kumar, Ingo Müller, et al.
Pageof 17

Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
The Lancet. Oncology|October 3, 2024
Development of a conceptual framework for an electronic patient-reported outcome (ePRO) system measuring symptoms and impacts of CAR T-cell therapies in patients with haematological malignanciesForam Khatsuria, Christel McMullan, Olalekan Lee Aiyegbusi, et al.
Translational Oncology|January 1, 2018
Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case-Control Study of Patients with Head and Neck Squamous Cell CarcinomaTrisha Wise-Draper, Arun Sendilnathan, Sarah Palackdharry, et al.
Cancer Research|April 3, 2003
PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancerElaine B Brunschwig, Keith Wilson, David Mack, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2004
15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancersMin Yan, Ronald M Rerko, Petra Platzer, et al.
Journal of Wound Care|March 20, 2025
Remote digital surgical wound monitoring and surveillance using smartphonesMelissa Rochon, Kylie Sandy-Hodgetts, Ria Betteridge, et al.
Oncotarget|April 19, 2017
Targeting CD157 in AML using a novel, Fc-engineered antibody constructChristina Krupka, Felix S Lichtenegger, Thomas Köhnke, et al.
Cardio-Oncology (London, England)|May 20, 2026
Cardio-oncology research prioritisation in the United Kingdom: national surveys of health care professionals, patients and carersGerard M Walls, Allyson Arnold, David Austin, et al.
Blood Advances|April 14, 2023
Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDSJustin Loke, Nicholas McCarthy, Aimee Jackson, et al.
The Journal of Infectious Diseases|March 18, 2021
A Human Dectin-2 Deficiency Associated With Invasive AspergillosisJames S Griffiths, P Lewis White, Magdalena A Czubala, et al.
Blood|October 5, 2017
Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2Hasan Hashem, Ashish R Kumar, Ingo Müller, et al.
Pageof 17